Christopher Kemmerer — Insider Trading History & SEC Filings
SEC CIK 1624926 — VP, Pharma Dev & Manufacturing
Christopher Kemmerer is a corporate insider tracked via SEC EDGAR filings. Officers, directors, and 10%+ beneficial owners must report transactions in their company's stock on Form 4, typically within two business days. This page shows Christopher Kemmerer's reported transactions, current holdings across companies, and filing history.
Frequently asked questions
Who is Christopher Kemmerer?
Christopher Kemmerer is a corporate insider (SEC CIK 1624926) with reported roles including VP, Pharma Dev & Manufacturing. This page tracks their SEC Form 4, Form 3, and Form 5 filings, current holdings, and transaction history.
How current is this insider data?
Insiders must report transactions to the SEC typically within two business days. finshort ingests new EDGAR filings continuously, so transactions appear shortly after they are filed.